Inspire Investing, LLC Vertex Pharmaceuticals Inc Transaction History

Inspire Investing, LLC

$959 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $3.4 Million - $3.81 Million	-18,755 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $276,922 - $326,564	1,477 Added 8.55%	18,755 $3.78 Million
Q1 2021 Apr 30, 2021	BUY	$207.02 - $241.31 $981,067 - $1.14 Million	4,739 Added 37.79%	17,278 $3.71 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $400,978 - $534,786	1,937 Added 18.27%	12,539 $2.96 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $46,528 - $55,164	-182 Reduced 1.69%	10,602 $2.89 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $895,606 - $1.17 Million	3,972 Added 58.31%	10,784 $3.13 Million
Q1 2020 May 08, 2020	SELL	$199.77 - $247.81 $198,771 - $246,570	-995 Reduced 12.74%	6,812 $1.62 Million
Q4 2019 Jan 24, 2020	SELL	$166.71 - $223.91 $141,036 - $189,427	-846 Reduced 9.78%	7,807 $1.71 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $186,177 - $209,540	1,120 Added 14.87%	8,653 $1.47 Million
Q2 2019 Jul 16, 2019	BUY	$164.61 - $190.37 $116,050 - $134,210	705 Added 10.33%	7,533 $1.38 Million
Q1 2019 May 16, 2019	BUY	$163.73 - $194.7 $242,811 - $288,740	1,483 Added 27.75%	6,828 $1.26 Million
Q4 2018 Feb 22, 2019	BUY	$151.91 - $192.21 $246,246 - $311,572	1,621 Added 43.53%	5,345 $886,000
Q4 2018 Feb 01, 2019	SELL	$151.91 - $192.21 $167,860 - $212,392	-1,105 Reduced 22.88%	3,724 $617,000
Q3 2018 Feb 22, 2019	BUY	$167.73 - $192.74 $7,044 - $8,095	42 Added 0.88%	4,829 $931,000
Q3 2018 Nov 07, 2018	BUY	$167.73 - $192.74 $118,585 - $136,267	707 Added 17.33%	4,787 $923,000
Q2 2018 Feb 22, 2019	BUY	$145.72 - $169.96 $251,221 - $293,011	1,724 Added 73.17%	4,080 $693,000
Q2 2018 Jul 19, 2018	BUY	$145.72 - $169.96 $123,279 - $143,786	846 Added 56.03%	2,356 $400,000
Q1 2018 Feb 22, 2019	BUY	$151.6 - $177.13 $228,916 - $267,466	1,510 New	1,510 $246,000
Q1 2018 Apr 13, 2018	SELL	$151.6 - $177.13 $199,808 - $233,457	-1,318 Closed	0 $0
Q4 2017 Feb 22, 2019	BUY	$137.28 - $155.55 $160,754 - $182,149	1,171 Added 796.6%	1,318 $198,000
Q4 2017 Feb 15, 2018	BUY	$137.28 - $155.55 $20,180 - $22,865	147	147 $22,000

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

227M

Call Options Held

1.21M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.8M
Shares

$13.3 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$11.5 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.5 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.8 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.45 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $127B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account